Fingerprint
Dive into the research topics of 'Ruxolitinib versus standard therapy for the treatment of polycythemia vera'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ruxolitinib versus standard therapy for the treatment of polycythemia vera
Alessandro M. Vannucchi, Jean Jacques Kiladjian, Martin Griesshammer, Tamas Masszi, Simon Durrant, Francesco Passamonti, Claire N. Harrison, Fabrizio Pane, Pierre Zachee, Ruben Mesa, Shui He, Mark M. Jones, William Garrett, Jingjin Li, Ulrich Pirron, Dany Habr, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
366
Scopus
citations